[SRNE] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
25-Apr-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -63.41%
YoY- 203.91%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 11,505 13,034 6,929 20,407 4,019 1,337 798 55.94%
PBT -73,068 -69,110 -55,746 -38,001 -12,724 -25,413 -10,207 38.78%
Tax 36 309 -3,122 -90,424 -701 1,186 1 81.61%
NP -71,502 -62,820 -49,776 12,425 -11,957 -23,476 -8,505 42.54%
Tax Rate - - - - - - - -
Total Cost 83,007 75,854 56,705 7,982 15,976 24,813 9,303 43.96%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -621.49 -481.97 -718.37 60.89 -297.51 -1,755.87 -1,065.79 -8.58%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.28 -0.34 -0.41 0.15 -0.23 -0.62 -0.23 3.32%
EPS Diluted -0.28 -0.34 -0.41 0.15 -0.23 -0.62 -0.23 3.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.